a total of 63 neutropenic patients receiving cytotoxic therapy for acute leukemia were randomly allocated to receive norfloxacin ( 400 mg every 12 hours ) or cotrimoxazole ( 160/800 mg every 12 hours ) to prevent bacterial infection .
C0028365
norfloxacin
C0004623
bacterial infection